Literature DB >> 2816935

Rhodococcus peritonitis in a patient treated with peritoneal dialysis.

E Brown1, E Hendler.   

Abstract

This report is of a patient treated with continuous ambulatory peritoneal dialysis who developed peritonitis attributed to a Rhodococcus species. The rhodococci are rarely pathogenic to humans, and there are no previous reports of peritonitis associated with these organisms. It is important for clinicians to be aware of these bacteria because they can be acid-fast and can be confused with mycobacteria. They are often reported as "diphtheroids" but should not be considered contaminants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816935     DOI: 10.1016/s0272-6386(89)80177-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.

Authors:  Omar Azzam; Amy Crowe; Cherian Sajiv; Basant Pawar
Journal:  BMJ Case Rep       Date:  2015-10-05

2.  First case of bloodstream infection caused by Rhodococcus erythropolis.

Authors:  Hisashi Baba; Toshi Nada; Kiyofumi Ohkusu; Takayuki Ezaki; Yoshinori Hasegawa; David L Paterson
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

Review 3.  Severe Rhodococcus equi pneumonia: case report and literature review.

Authors:  J Vestbo; J D Lundgren; J Gaub; B Røder; E Gutschik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

4.  The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells.

Authors:  M K Hondalus; M S Diamond; L A Rosenthal; T A Springer; D M Mosser
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Rhodococcus erythropolis encephalitis in patient receiving rituximab.

Authors:  Satish R Bagdure; Mark A Fisher; Michael E Ryan; Faisal A Khasawneh
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.